Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion from Insulin Glargine U100 to Glargine U300 in Youth with Type 1 Diabetes
TCTR20210901004Phase 4Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine U300 in diabetes mellitus type 1 (T1D), sponsored by Ratchadaphiseksomphot Endowment Fund. Started Sep 2021; status: completed.
02
Drugs
insulin glargine U300
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on TCTR20210901004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210901004.